参考文献/References:
[1]Liu J,Liang WN,Jing WZ,et al.Countdown to 2030:eliminating hepatitis B disease, China[J].Bull World Health Organ,2019,97(3):230-238. [2]邱思瑜,华丽群,姚美燕.护理专案行动提高门诊慢性乙型肝炎患者自我管理能力[J].护理学杂志,2019,34(10):49-51.[3]中华医学会肝病学会,中华医学会感染病学会.慢性乙型肝炎防治指南(2019年版)[J].中华肝脏病杂志,2019,27(12):938-960. [4]Kong LN,Zhu WF,He S,et al.Development and preliminary validation of the chronic hepatitis B selfmanagement scale[J].Applied Nursing Researc,2018,41:46-51.[5]施素华,王培,邹琼芳,等.“互联网+”营养教育在维持性血液透析患者中的应用[J].中华护理杂志,2021,56(1):33-38.[6]丁霞,黄中伟.全生命周期的健康管理对老年慢性阻塞性肺疾病患者肺功能的影响[J].中国老年学杂志,2021,41(1):53-56.[7]李影,黄卫新.多学科团队合作模式对老年糖尿病患者个体化健康教育的效果评价[J].吉林医学,2018,39(5):992-994.[8]黄琴,何丽芸,张甜,等.个案管理模式对HIV/AIDS患者心理弹性及自我管理能力的影响[J].护理学杂志,2018,33(5):80-82.[9]陈曦.医务人员的医患关系、组织支持感与工作投入的关系研究[D].南宁:广西大学,2016.[10]贾伟平.慢性病防治管理新趋势的思考[J].中华内科杂志,2021,60(1):1-4.[11]胡欢欢,郑静,李冬梅,等.卒中健康管理门诊的建立与实践效果研究[J].解放军护理杂志,2021,38(2):48-51.
相似文献/References:
[1]林晓岚,郑丽花,陈苑莉,等.微信随访对慢性乙型肝炎患者抗病毒治疗效果和
生活质量的影响研究[J].医学信息,2018,31(10):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
LIN Xiao-lan,ZHENG Li-hua,CHEN Yuan-li,et al.Effect of WeChat Follow-up on Antiviral Treatment and Quality of Life in Patients with Chronic Hepatitis B[J].Journal of Medical Information,2018,31(05):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
[2]林晓岚,陈苑莉.慢性乙型肝炎患者治疗依从性及其对生活质量的影响[J].医学信息,2018,31(13):168.[doi:10.3969/j.issn.1006-1959.2018.13.052]
LIN Xiao-lan,CHEN Yuan-li.Treatment Compliance of Patients with Chronic Hepatitis B and its Influence on Quality of Life[J].Journal of Medical Information,2018,31(05):168.[doi:10.3969/j.issn.1006-1959.2018.13.052]
[3]陈 欢,李秀惠.急、慢性乙型肝炎及乙肝肝硬化患者
肝功能及血脂水平分析[J].医学信息,2019,32(12):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
CHEN Huan,LI Xiu-hui.Analysis of Liver Function and Blood Lipid Levels in Patients with Acute,
Chronic Hepatitis B and Hepatitis B Cirrhosis[J].Journal of Medical Information,2019,32(05):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
[4]吴 刚,吴锦瑜.HBeAg阴性慢性乙型肝炎患者血清25-羟基维生素D3的检测及临床意义[J].医学信息,2018,31(19):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
WU Gang,WU Jin-yu.Detection and Clinical Significance of Serum 25-hydroxyvitamin D3 in Patients with HBeAg-negative Chronic Hepatitis B[J].Journal of Medical Information,2018,31(05):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
[5]叶向荣.恩替卡韦治疗慢性乙型肝炎病毒感染的临床价值评价[J].医学信息,2018,31(22):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]
YE Xiang-rong.Clinical Evaluation of Entecavir in Treatment of Patients with Chronic Hepatitis B Virus Infection[J].Journal of Medical Information,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]
[6]汪晓凤,邵和军.慢性乙型肝炎抗病毒治疗进展[J].医学信息,2019,32(04):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
WANG Xiao-feng,SHAO He-jun.Progress in Antiviral Therapy for Chronic Hepatitis B[J].Journal of Medical Information,2019,32(05):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
[7]傅 蕊,李士欣,周国强,等.床旁超声预测慢性乙型肝炎患者胃镜检查围麻醉期误吸风险的临床价值[J].医学信息,2019,32(08):123.[doi:10.3969/j.issn.1006-1959.2019.08.035]
FU Rui,LI Shi-xin,ZHOU Guo-qiang,et al.Clinical Value of Bedside Ultrasound in Predicting the Risk of Aspiration during Perioperative Anesthesia in Patients with Chronic Hepatitis B[J].Journal of Medical Information,2019,32(05):123.[doi:10.3969/j.issn.1006-1959.2019.08.035]
[8]张媛媛,徐 曼.慢性乙型肝炎患者e抗原消失的临床特点[J].医学信息,2019,32(10):105.[doi:10.3969/j.issn.1006-1959.2019.10.033]
ZHANG Yuan-yuan,XU Man.Clinical Features of e Antigen Disappearance in Patients with Chronic Hepatitis B[J].Journal of Medical Information,2019,32(05):105.[doi:10.3969/j.issn.1006-1959.2019.10.033]
[9]罗 丹,梁惠卿,吴耀南.吴耀南教授基于“伏邪”理论治疗慢性乙肝的验案举隅[J].医学信息,2019,32(19):158.[doi:10.3969/j.issn.1006-1959.2019.19.052]
[10]周腾腾,郑 莹,梁恵卿,等.蛋白质组学在慢性乙型肝炎常见中医证型中的研究[J].医学信息,2019,32(20):30.[doi:10.3969/j.issn.1006-1959.2019.20.009]
ZHOU Teng-teng,ZHENG Ying,LIANG Hui-qing,et al.Study on Proteomics in Common TCM Syndromes of Chronic Hepatitis B[J].Journal of Medical Information,2019,32(05):30.[doi:10.3969/j.issn.1006-1959.2019.20.009]